Table 1. Predicted binding free energies and inhibitory activities of screening hits.
Prazoles | ICM scores a | Kd (μM) b | IC50 for HCT116 cell activities (μM) |
---|---|---|---|
Esomeprazole | −26.24 | n.bc | >500 |
Omeprazole | −26.24 | 174.3 ± 3.1 | 348.3 ± 7.3 |
Ilaprazole | −31.88 | 111.0 ± 2.3 | 40.0 ± 0.6 |
Pantoprazole | −25.65 | 24.2 ± 2.3 | 153.0 ± 8.5 |
Lansoprazole | −27.35 | 241.6 ± 5.2 | 102.9 ± 4.1 |
Disuprazole | −19.36 | n.bc | >500 |
Rabeprazole | −8.63 | 324.2 ± 6.3 | >500 |
a. Docking score/interaction potential of compounds with TOPK (kcal/mol).
b. The Kd value is automatic calculated by the curve fitting, and presents as means ± SD for three experiments.
c. n.b. is no clear binding detected in the MST measurement.